Pharma/Biotech Stocks to Watch This Prostate Cancer Month

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Oct. 26) read more.....»»

Endocyte licensed a prostate cancer drug a year ago for an upfront payment of $12 million. Now, it’s being bought by the Swiss pharma giant Novartis for more than $2 billion......»»

Drugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants......»»

Four pharma/biotech companies are set to release earnings .....»»

Gold edges higher Wednesday as bulls look to build on a rally that lifted the yellow metal to its highest finish since April a day earlier......»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) Alector Inc (NASDAQ: ALEC) (IPOed early Febru.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 19) read more.....»»

European markets were mostly down on Monday, after last week’s highs, as investor continue to watch trade negotiations between the U.S. and China unfold.....»»

European markets were mostly down on Monday, after last week’s highs, as investor continue to watch trade negotiations between the U.S. and China unfold.....»»

Here's why Viking Therapeutics, Cambrex, and Sarepta Therapeutics are all solid biotech plays this month......»»

Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs Wednesday. Down In The Dumps (Biotech stocks hitting 52-week lows on Jan. 23) read more.....»»

2 Biotech Stocks On Watch Early In The Week.....»»

U.S. stock futures head lower on Thursday, putting the indexes in position to end a two-day rise as investors digest quarterly results and watch for impacts from a nearly one-month partial shutdown of the government......»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks The following biotech stocks struck 52-week highs Jan. 9:  read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week highs on Jan. 8) read more.....»»

The third multibillion-dollar bu.....»»

When it comes to the acquisition of cancer-treating upstarts, Bristol-Myers has been here before.....»»

These biotech and pharma stocks are valued at or below eight times next year's profit projections......»»

HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corpo.....»»

The developmental biotech offers high reward, but for high riskRelated Stocks: NTEC,.....»»